Effects of Persistent Atrial Fibrillation on Serum Galectin-3 Levels-Reference-Cited by-同舟云学术

Effects of Persistent Atrial Fibrillation on Serum Galectin-3 Levels

Published:2015-03 Issue:5 Volume:115 Page:647-651
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Gurses Kadri Murat,Yalcin Muhammed Ulvi,Kocyigit Duygu,Canpinar Hande,Evranos Banu,Yorgun Hikmet,Sahiner Mehmet Levent,Kaya Ergun Baris,Ozer Necla,Tokgozoglu Lale,Oto Mehmet Ali,Guc Dicle,Aytemir Kudret

Funder

Hacettepe University Scientific Research Projects Coordination Unit

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference27 articles.

1. Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction;Sharma;Circulation,2004

2. The relationship between serum galectin-3 and serum markers of cardiac extracellular matrix turnover in heart failure patients;Lin;Clin Chim Acta,2009

3. Galectin-3: a novel blood test for the evaluation and management of patients with heart failure;McCullough;Rev Cardiovasc Med,2011

4. Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community;Ho;J Am Coll Cardiol,2012

5. Plasma galectin 3 and heart failure risk in the Physicians' Health Study;Djousse;Eur Heart Fail,2014

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into the Role of Galectin-3 as a Diagnostic and Prognostic Biomarker of Atrial Fibrillation;Disease Markers;2023-10-09

2. The role of galectin-3 in atrial fibrillation;Journal of Molecular Medicine;2023-09-29

3. The Role of Galectin-3 in Heart Failure—The Diagnostic, Prognostic and Therapeutic Potential—Where Do We Stand?;International Journal of Molecular Sciences;2023-08-23

4. Long-Term Changes in the Biomarkers of Left Atrial Fibrosis after Pulmonary Vein Isolation for Paroxysmal and Persistent Atrial Fibrillation;Reviews in Cardiovascular Medicine;2023-06-12

5. L1 cell adhesion molecule may be a protective molecule for atrial fibrillation in patients with valvular heart disease;Heliyon;2023-06